Table 3.
Operative morbidity and mortality, adjuvant treatment commenced, and completed details of nondiabetes versus diabetes patients, including metformin and insulin treated subsets.
| No diabetes N = 875 |
Diabetes N = 241 |
Metformin group N = 99 |
Insulin group N = 24 |
|
|---|---|---|---|---|
| Renal function | ||||
| μmol/L, mean Cra | N/A | 87 | 80 | 92 |
| n (%) eGFR < 60b | N/A | 49 (22%) | 17 (18%) | 32 (25%) |
| Surgical complications, n (%) | 185 (21.1) | 67 (27.8) | 31 (31.3) | 7 (29.2) |
| Operative mortality, n (%) | 14 (1.6) | 5 (2.1) | 1 (1.0) | 1 (4.2) |
| Adjuvant chemotherapy commenced, n (%) | 217 (24.8) | 33 (13.7) | 11 (11.1) | 4 (16.7) |
| Adjuvant chemotherapy completed, n (%) | 593 (67.8) | 168 (69.7) | 63 (63.4) | 18 (75) |
aSerum creatinine.
bNumber and percentage of patients with estimated glomerular filtration rate less than 60 mL/min/1.73 m2.